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Exploring health care professionals views on alternative approaches to cancer follow-up 




Implementing alternative models for the provision of follow-up care for patients treated for 
cancer has been the focus of cancer care reform in the United Kingdom (UK) over the last 
decade (Macmillan Cancer Support, 2008; Department of Health, 2010; NHS Improvement, 
2010; NCSI, 2013; NHS England, 2016). The traditional model of regular hospital outpatient 
appointments is costly to the UK’s National Health Service (NHS) and is practically and 
financially unsustainable, given the increasing numbers of cancer survivors across Europe 
(Ferlay et al, 2013). Current follow-up practices do not meet cancer survivors’ psychosocial 
and information needs, fostering reliance on healthcare professionals (HCPs) and hindering 
the ability to self-manage (DoH, 2010; Macmillan Cancer Support, 2008). There is no 
standardised practice across European countries to meet the needs of cancer survivors and 
more research is needed to promote the long-term well-being of patients diagnosed with 
cancer (Lagergren et al, 2019)   
 
In the UK, a rapid review of service provision following cancer treatment concluded that 
addressing the needs of cancer survivors, particularly with the predicted increase in 
numbers, required new models of follow-up (NHS Improvement 2010). Studies of 
alternative models of follow-up including General Practitioner (GP) led, nurse-led, and 
patient-initiated have reported effectiveness and been well received by patients (Grunfeld 
et al, 1996; 1999; Moore et al, 2000; Brown, 2002; Murchie et al, 2010; Beaver et al, 2009; 
2012; 2017) but have not been routinely adopted into practice at a national level. In 2013 
the UK’s National Cancer Survivorship Initiative (NCSI) recommended an integrated package 
of care (Recovery Package) that included: a structured Holistic Needs Assessment (HNA) 
that incorporates a care plan based on an assessment of physical, practical, emotional, 
spiritual and social needs, treatment summaries for patients and GP’s, patient education 
and support events (health and wellbeing clinics) and a cancer care review in primary care. 
These elements of the Recovery Package were considered the foundation for achieving 
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quality outcomes for cancer survivors (NCSI, 2013) with the expectation that it will be 
offered to each person affected by cancer by 2020. A report aimed at supporting 
commissioners and clinical networks to drive improved outcomes for patient centred care, 
outlines the need for risk stratified pathways of care (NHS England, 2016). Hence, 
individuals deemed at low-risk of recurrence and late effects (physical and psychosocial), 
should be encouraged toward supported self-management with timely re-access and/or 
remote monitoring (NHS England, 2016). Patients considered to have a medium or high risk 
of recurrence,  complex care needs and/or a poor prognosis (e.g. being treated for palliation 
rather than with curative intent) would receive either planned co-ordinated care or care 
from specialist services.  
 
Despite the drive towards increased self-management and the need for follow-up services 
to be better managed, it is still not clear how alternative models of care have been 
implemented or what barriers / facilitators have been identified in NHS institutions across 




This study aimed to explore the views of HCP’s, NHS managers and commissioners of 
services on alternative strategies for follow-up care, and the perceived barriers and 
facilitators to implementation of the Recovery Package for patients who had completed 
treatment for cancer.  
 
Method 
As this study was exploratory, a qualitative approach was taken involving individual 
telephone interviews with study participants.  Semi-structured interviews sought 
participants’ views and experiences of key aspects of cancer care follow-up: sustainability of 
the traditional model of hospital outpatient follow-up; whether alternative models of 
cancer follow-up had been implemented; barriers and facilitators which contributed to 
implementation of new models; aspects of the NCSI Recovery Package (HNA, treatment 





Participants included HCP’s  (Clinical Nurse Specialists (CNS), Lead Cancer Nurses, consultant 
surgeons, oncologists and  GPs), commissioners of cancer services and NHS managers who 
had responsibility for providing follow-up care for cancer patients. Clinical nurse specialists 
are nurses with advanced nursing skills within a specialist clinical area. They co-ordinate 
patient care, and provide information and support for patients and their families. In cancer 
care, they are employed in a number of different specialist areas. Lead Cancer Nurses 
provide professional leadership to clinical teams.  NHS managers co-ordinate the complex 
range of services provided by the NHS. In cancer care, NHS managers take a leading role on 
driving improvements in patient pathways and provide leadership and management support 
to clinical staff to ensure patients and their families receive high quality care and support. 
Commissioners of services in cancer are senior managers responsible for the planning, 
prioritisation, purchasing and monitoring of health care services. To ensure representation 
of views across the UK, participants from primary and secondary care, commissioning 
groups and national cancer centres were invited to participate. Participants were located in 
a diversity of geographical regions including Scotland, Wales, the Midlands, Yorkshire, the 
North West, South East and South West of England.  
 
A combination of convenience and snowball sampling was utilised to identify participants. A 
study advisory group comprised individuals who had clinical, commissioning and managerial 
experience 
 
 Access and Recruitment   
Potential participants were sent an introductory e-mail outlining the background, rationale 
and aims of the study. A participant information sheet and consent form were attached, 
inviting them to participate in an individual telephone interview, or face to face if preferred 
if they had more than one years’ experience (clinically or managerially) providing follow-up 
services for patients who had been treated for cancer. Electronic agreement to participate 
served as confirmation of consent. All participants had experience of working in cancer care. 
A mutually agreed date and time for interview was arranged.  Interviews were conducted by 
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one researcher unknown to the participants. With consent, interviews were digitally 
recorded and subsequently transcribed.  
 





Interviews were transcribed verbatim and uploaded into MAXQDA, a software package for 
qualitative data management (www.maxqda.com). The data were independently reviewed 
and analysed using thematic analysis (Braun & Clarke, 2006) by two of the authors who 
were not involved in the interviews. Each interview was read several times and coded into 
significant, recurrent themes and subthemes which reflected the meaning of the overall 
dataset. Any differences were resolved through discussion. 
 
Findings 
Twenty-one individuals agreed to participate; 19 interviews were conducted over the 
telephone and two face-to-face.  Participants had been in their current post for a mean of 7 
years (ranging from 1.5 to 18 years). The posts held by participants are presented in Table 1. 
Seven themes emerged from the data; sustainability and capacity, cost implications, primary 
care, self-management, Recovery Package, resistance to change, and visions for the future. 
(insert Table 1) 
Sustainability and capacity  
There was consensus that traditional, hospital-based follow-up for all patients following 
cancer treatment was unsustainable. Current services were struggling to accommodate the 
number of patients seen within clinical settings, due to increased incidences of cancer and 
survival rates.  
 
Traditional hospital follow-up was considered suitable for patients with complex needs, 
rarer forms of cancer and/or a poorer prognosis. Risk stratification was considered a vital 
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element of any future strategy but, if early detection of recurrence could lead to curative 
treatment, then hospital follow-up was considered important.   
   
‘So in certain tumour groups I would absolutely say it’s very important that people 
are still monitored within the clinical team with that expertise…a very good example 
of that might be in something like anal cancer… it’s probably  very appropriate that 
that patient group is followed up within a hospital setting with the experts.’  (ID 19 
consultant nurse)  
 
All participants reported that their institutions had attempted to implement alternative 
models of care, with varying degrees of progress and success. Most alternative models of 
follow-up were in the developmental or early phases of implementation, focussing on 
patients who had completed treatment for common cancers, such as breast and prostate.  
  
Nurse-led approaches, particularly telephone follow-up, were common and had been in 
place for a number of years at some locations. Implementing telephone follow-up was 
considered reasonably straight forward, as it required replacing a face- to- face service with 
a telephone call and had widespread support. This mode of follow-up care was reported to 
suit patients who did not necessarily require a physical examination. However, telephone 
follow-up was viewed as a useful stop gap, not a long-term solution, as it was not possible 
to follow-up all cancer survivors in this way due to workforce issues and a lack of succession 
planning.    
  
‘They’re [clinical nurse specialists] the key people and there are big workforce 
implications there because they don’t grow on trees…so if you have more patients go 
into a nurse led follow-up well that releases your oncologist or your consultant, but 
you’ve got to have the nurses, they take time to learn and train up, so it, it’s got to 
kind of happen at the pace at which people can skill up and come into it.’ (ID 04 GP & 
Commissioner)  
 
Remote tracking was reported as particularly beneficial for patients whose follow-up care 
required regular scans or blood tests as results could be communicated and accessed via 
post or, in some cases, online. However, it was noted that flexibility would need to be built 
into community-based follow-up to ensure that patients could be easily recalled if there was 




Cost implications  
The financial burden associated with traditional follow-up was a recurring theme, not only 
in terms of costs to the NHS, but also costs for patients. Costs to patients included the 
emotional costs of raised anxieties prior to appointments and financial costs in terms of 
travelling and time out of work.   
  
‘…we see patients who go for a scan, lie awake for two nights before their 
appointment, which is three weeks after their scan, worrying about has their cancer 
come back, go to the appointment, pay … four pounds to park, wait an hour and a 
half to see the specialist who briefly says “oh your scan’s fine that’s lovely no 
problem, see you in a year”.’ (ID 04 GP & Commissioner)  
 
It was widely acknowledged that introducing new ways of working would require 
investment, but resources were limited. Some initiatives had been pump primed (a 
temporary investment of funds to stimulate development and implementation of elements 
of the recovery package) by charitable organisations (e.g. Macmillan Cancer Support, 
Prostate Cancer UK) but there was concern over how the initiatives could be sustained once 
the initial funding period ended.  Resources needed to be available so that patients could be 
prioritised according to greatest need and highest risk of recurrence. However, there was 
concern that there was little incentive for NHS hospital Trusts (which provide secondary 
care) to give up hospital follow-up as they would lose their payment for follow-up 
appointments.   
  
‘Imagine it for each patient with breast cancer that the tariff for seeing somebody in 
outpatients is a hundred pounds, and there’s two thousand patients that are seen 
four times a year … but then imagine that disappears…it’s a disincentive for acute 
Trusts to change….’ (ID 14 GP  & Clinical Lead for Cancer)  
  
  
Patient-initiated approaches would also require funding and resources. Participants argued 
that fewer hospital appointments did not equate to no follow-up as systems still needed to 




 ‘I think the challenges have been to ensure that we have commissioning agreement, 
that we’re paid. Just because we’re not seeing the patients doesn’t mean that we’re 
not still following them up in as much as we are still organising all of the 
surveillance… I think that the challenge is, is helping the commissioners and the GPs 
understand that we’re not just throwing patients out there and saying, get on with it, 
we are still doing the follow-up, but it’s in a very different way,’ (ID 08 Head of 
Cancer Nursing)  
 
 
A service specification was viewed as a useful lever when implementing new models. The 
importance of communication with commissioners was strongly emphasised. Funding 
would still be required for any alternative approach and any new approach would need to 
be commissioned accordingly so that funding was not simply cut.   
  
‘The facilitating factors from our point of view is having a service specification that 
states very clearly we expect to see this stratified individual approach to follow-up 
and you’ve got that contractual lever then if it’s in the service specification.’ (ID 05 
Cancer Commissioning Manager)    
  
 
Primary care   
Stronger links between secondary and primary care were advocated to enhance patient 
experiences of follow-up, particularly promotion of patient-initiated approaches. If patients 
were to be discharged back to primary care, then a link person was required to ensure 
patients knew who to contact with any concerns.  While some participants felt this could be 
done by an administrator, others were adamant that a CNS should undertake this role. If 
primary care were to take on more responsibility for follow-up, they would need more 
specialist nurses to link between primary and secondary care. A clear distinction was 
expressed on the roles of specialist nurses in primary and secondary care, with 
recommendations that primary care nurses address long-term follow-up and hospital-based 
nurses address more acute needs of newly diagnosed patients.  
There were cost implications for primary and secondary care if GP’s had a more prominent 
role in follow-up. However, the GP’s who participated indicated that they could carry out 
follow-up, especially for patients treated for prostate cancer who would require PSA testing 
and monitoring, but only if self-management approaches were promoted and 
commissioning was altered to reflect the change in service provider. GP’s would not be able 
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to add to their workload by providing follow-up services unless they were appropriately 
funded and trained. GP’s would also need rapid access back to specialist services if they had 
any concerns, and training to ascertain the tests and investigations required for patients.  
 
Participants expressed concern that patients discharged early may become ‘lost’ in the 
system unless ‘safety nets’ were in place so that patients and GP’s knew who to contact 
regarding problems and systems for rapid access to secondary care services were in place.  
Despite concerns, there was a favourable view on primary care practitioners taking a more 
prominent role in follow-up as primary care practitioners see the patient in the context of 
their environment and overall health and may have more understanding of patients’ 
individual needs and ability to self-manage.    
 
Self-management  
One of the criticisms aimed at the traditional model of hospital-based follow-up was that it 
was not ‘patient-friendly’ and gave ‘artificial support’. The traditional model was perceived 
as offering a false sense of security which deterred patients from taking responsibility for 
their own health and being attentive to signs of recurrence between appointments.    
  
‘We do have patients who come back who had symptoms weeks ago but thought oh 
it’s alright I’ve got an appointment coming up.’ (ID 02 Lead Cancer Nurse)  
   
  
Participants emphasised the importance of describing the pathway for alternative models of 
follow-up at the beginning of a patient’s cancer journey to manage their expectations. HCP’s 
could emphasise the need for patients to be more involved in managing their own care and 
triggering action if and when necessary.   
 
It was perceived that patients associated the traditional model with trust, and trust would 
need to continue if alternate models were introduced. Patients currently expected to return 
to hospital clinics on a regular basis and to be given a reassuring message that all was well. 
Concern was expressed that patients may feel unsupported or isolated if they were 
discharged immediately after treatment with no support mechanisms in place. It was felt 
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that patients needed signposting to services and resources that could be readily accessed if 
required.   
  
‘… you need to manage patients expectations around that being the sort of follow-up 
that they can expect…if you're not careful and you follow-up people up at sort of 
arm’s length in that way, it might actually exacerbate the problem of people feeling 
isolated rather than improve it.’ (ID 18 Survivorship Network Manager)  
  
 Supported self-management was advocated as a key component of cancer care generally, 
regardless of stage in the cancer pathway, and strongly favoured by participants, although 
variation in implementation activities was reported. However, concerns were expressed 
about older patients who may not understand the new self-management approaches to 
care.   
 
‘What I’m finding is with the, the older patient is that they struggle with that 
ownership being put back onto them ‘cos they’re used to the paternalistic approach… 
younger patients seem to accept it better’ (ID 13  Consultant Nurse)  
 
Prostate cancer was viewed as being particularly suitable for self-management approaches 
as well as cancers with a good prognosis and those with obvious signs and symptoms of 
recurrence. Rapid access back to specialist services needed to be in place and it could not be 
assumed that discharging people from hospital clinics would not require resources.   
  
‘I think the infrastructure that's currently in place certainly here isn't enough to 
support that [supported self-management] because if you’re sending the patients off 
you've got to give them clear routes back in  and have things in place that can 
support them and we've got a few plans for the future that, that are going to involve 
a considerable amount of investment and it's a bit of a leap of faith for people at the 
minute because it's not been done before…’ (ID 17 Lead Cancer Nurse) 
 
Recovery Package 
Most participants were aware of the different elements of the Recovery Package (HNA, risk 
stratification, treatment summaries, health and well-being clinics, cancer care review) but 
different aspects were being implemented at different rates. It was acknowledged that 





Only one participant (ID11) reported on all aspects of the Recovery Package being 
implemented in secondary care, utilising risk stratification for breast cancer patients. Similar 
pathways had been written for colorectal and prostate cancer patients at this location with 
a pathway for skin cancer patients in progress. Nurse specialists had taken on extra 
workloads to sustain the programme and funding had been received from a charitable 
source. The challenges of sustaining the programme of work and changing traditional 
practices were acknowledged and effective communication with commissioners of services 
was highlighted as a facilitating factor.     
  
‘We’re already having talks with our commissioners which are being led by our local 
cancer network to look at how we can  jiggle the funds around really and commission  
the Recovery Package activity, but that would be on the proviso obviously that we 
reduce the follow-up ‘cos there won’t be more money and we’ve got a lot more 
patients coming in…’ (ID 11 Lead Cancer Nurse)  
  
Two participants had reported that a quality incentive payment, where funding is withheld 
until quality targets are achieved, may be useful in supporting the introduction of HNA’s, 
care plans and treatment summaries to inform a cancer care review in primary care.     
   
The Recovery Package was generally supported by participants, although considered to be 
useful in theory but not working efficiently and effectively in practice as yet. There was a 
willingness to implement aspects of the Recovery Package but uncertainly as to how this 
could be effective without additional support and resource. Adequate resources needed to 
be in place to create ‘sustainable change’ (ID18). There was concern about identifying 
patients’ needs without the resources and services being in place to meet them.  
  
‘You know if we say okay, this person really has got quite severe psychological 
consequences of their cancer and treatment and they need a level 4 psychotherapist, 
we haven’t got access to a level 4 psychotherapist…So it’s all very well doing the 
needs assessment and it sounds, you know, it’s great for the patient to say how 
they’re feeling but if you can’t address those needs, why find out if they have those 





Treatment summaries were in place at a number of locations but concern was expressed 
that they were not always understandable to GP’s and were written for the benefit of 
hospital doctors.   
  
‘Make them [treatment summaries] understandable to a GP you know, they’re not 
written for GP’s they’re written for the hospital doctor so that when they see them 
again in clinic they understand them but they’re not really written with primary care 
in mind.’ (ID 20 GP)  
  
There was variability as to whether the HNA was being implemented in practice, although it 
was not always referred to as an HNA. It was generally accepted that patients needed to 
have their needs assessed but there was a lack of clarity as to when this should be carried 
out and by who although most said it was carried out by nurses. Participants were unclear 
who would carry out the HNA if patients came to a regional cancer centre from a local 
hospital for treatment and then returned following treatment for follow-up care. There 
were stark differences reported between locations that had financial support from 
charitable organisations (e.g. Macmillan Cancer Support) and those that did not in carrying 
out HNA’s.  
  
‘They’re part of a Macmillan pilot, so their nurses now have an iPad with holistic 
needs assessment on, the patient has the iPad in the waiting room and does their 
own holistic needs assessment by putting their finger on the boxes. It magically goes 
up a net somewhere and comes back down so that when the patient comes through  
to the nurse it’s come back down with all the information of holistic needs 
assessment has fallen into a care plan’ (ID 04 GP & Commissioner)  
 
‘For the breast patients, we didn’t offer holistic needs assessments, unfortunately, 
early on and the clinical nurse specialists were over worked, had no capacity to do 
that, and whilst we have a support worker she can do some holistic needs 
assessment, but certainly not on every patient… (ID 08 Head of Cancer Nursing)  
  
 Those participants working in areas that had implemented health and wellbeing clinics had 
attempted to incorporate a range of different elements within their clinics to cater for 
patients differing needs. Interventions focused on educating patients and encouraging 
supported self-management and ranged from short 4-6 week courses to more prolonged 
12 
 
interventions. Different terminology was often used, including ‘hubs’, ‘market places’, 
‘workshops’, ‘events’, and the ‘Coventry model’ based on the HOPE  
(Helping Overcome Problems Effectively) courses which have been adopted by Macmillan 
Cancer Support and are freely available.  
  
Health and well-being clinics needed to be tailored to different cancer types and were 
perceived as inappropriate for patients with a poor prognosis. There was a lack of clarity on 
the most appropriate time to offer such clinics and participants felt they were more likely to 
promote self-management if offered at an earlier stage. However, it was also reported that 
health and well-being clinics might not necessarily act as a replacement for hospital-based 
follow-up but could provide an additional support mechanism, with additional resource 
implications.   
   
‘What we found was that patients said it was too late in the pathway for health and 
well-being clinics; it was far too late at two years and they’d struggled for two years 
with needing some advice… it’s an additional support for patients, … we’ve had some 
really positive feedback, and I’m sure it does support them throughout the rest of the 
pathway,  but it certainly doesn’t reduce the number of visits that they have, so yeah 
that’s been quite an interesting find along the way.’ (ID 02 Lead Cancer Nurse)  
   
Where funding was not readily available, participants reported working closely with 
established charities to ensure patients could access additional support and information. 
Although some health and wellbeing clinics had been primarily designed for cancer specific 
patient groups, their ability to offer support for generic issues faced by all cancer patients 
had enabled some clinics to offer the service to a wider range of patients.  Participants 
voiced concern about being able to sustain clinics that had been implemented without 
additional funding.  
 
 
Resistance to change   
Participants acknowledged that changing the cultural view of follow-up may be problematic 
for both patients and HCP’s. Medical consultants were often perceived as resistant to 
change, wanting to continue seeing patients in hospital clinics. However, it was 
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acknowledged that the situation was highly complex and the differing needs of different 
types of cancer patients heightened the degree of complexity.   
 
Resistance to minimalist approaches to follow-up was anticipated if a particular cancer type 
had a higher likelihood of recurrence (e.g. ovarian). The different personalities of service 
providers was also considered an issue in trying to implement change as was a general 
resistance to any new initiative.   
 
 ‘Unfortunately the NHS when challenged with change usually puts up a lot of 
resistance to try and facilitate or otherwise and we've experienced that with 
[nurse’s name] telephone, this is a nurse specialist, her telephone clinic because 
we've had tremendous difficulties in getting appointments arranged on our patient 
management system which means she has to get her notes herself and sort out the 
follow-up and there's no tracking of patients that don't turn up so it's, it's, we could 
have people that are more adaptable to support the service but unfortunately we 
haven't had that.’ (ID 15 Surgical Oncologist)   
  
Clinicians welcomed a balanced range of patients in their clinics, including those who had 
complex problems and those who were well but returning for routine monitoring. Hence, 
clinicians many not want to ‘let go’ of some of their patients, particularly as some expressed 
concern regarding a potentially negative emotional impact on clinicians of only seeing those 
patients with complex problems.   
 
The lack of evidence on the effectiveness of alternative strategies, particularly those that 
supported minimalist and patient-led approaches, was a concern. Evidence that was 
available could be ignored, with practitioners defaulting back to what was known and 
familiar. Waiting for evidence to become available was seen as a delaying factor and there 
was a strong impetus to implement change before the evidence was available.    
  
 ‘I think the evidence is there. I think the problem with many of these trials… is 
actually implementing it into practice afterwards because it's all well and good 
during the trial but then very rarely do people actually implement it afterwards.’(ID 





Visons for the future  
The survivorship agenda was perceived as a fairly recent initiative. It was recognised that 
large organisations had numerous priorities and agendas and survivorship was not a top 
priority at all locations. Achievable milestones were needed that could highlight progress.   
When participants discussed how cancer follow-up care could evolve in the future, it was 
widely regarded that technology could, and should, be better utilised. One participant 
suggested introducing more tele health-based appointments. Enabling patients to take 
control of their own information was suggested. Participants expressed surprise that 
technological advances ha d not been evident in follow-up care.  
  
‘I stopped writing notes twenty years ago when I first became a GP in 1996 …, 
everything was entered onto the computer, why isn’t that the case in hospitals, why 
isn’t everything, and then you could just put it on a stick [memory stick/flash drive] 
and patients could carry their notes around on a stick.’ (ID 21 GP)  
 
There was a call for more evidence on the safety and effectiveness of new models and a 
need for a more standardised national approach with concerns expressed about the 
potential for litigation.  
‘Trusts run the risk of exposing themselves to, to potentially law cases further down 
the road, if we haven't got the evidence to say this is safe follow-up for these 
patients and this is what we're all agreeing to nationally. If you've got one hospital 
doing one thing and another hospital doing something else;  if a patient from 
Hospital A gets a recurrence you know can we confirm or could we prove that if 
they'd been followed up the way Hospital B follows them up that it wouldn't have 
been picked up earlier and that's the concern I've got really.’ (ID 17 Lead Cancer 
Nurse)  
 
Participants acknowledged that changing the current format of follow-up cancer care would 
take time. However, one participant emphasised how ‘small wins’ and setting realistic and 
achievable milestones could still make a difference to patient’s lives, in addition to keeping 






This study achieved its aim to explore the views of HCP’s, NHS managers and commissioners 
of services on alternative strategies for follow-up care, and the perceived barriers and 
facilitators to implementation of alternative approaches and/or the Recovery Package for 
patients who had completed treatment for cancer. Participants welcomed the survivorship 
agenda, implementing aspects that they could, with or without additional resources. The 
findings indicated that communication between primary and secondary care, and patients 
and healthcare providers could be improved. Accessing and sharing of information between 
primary and secondary care is an essential aspect of future implementation with more 
efficient use of technology.  Digitisation of healthcare systems in the UK is ongoing. 
Although digital record keeping in primary care is widespread, the same does not apply to 
secondary care and the funding for development of separate systems in primary care and 
secondary care has not facilitated the creation of an integrated healthcare record (National 
Audit Office, 2013). Technological advances in healthcare are not as advanced as those in 
sectors such as banking and retail, which have aimed to improve the consumer experience 
and make services more accessible and convenient (Honeyman, Dunn, and McKenna 2016). 
The Wachter report (2016) recommends that interoperability of healthcare records 
between primary and secondary care across regions in the UK should be a priority for 2019 
and that by 2022 national interoperability should be in place with penalties for those 
healthcare trusts who do not comply. Successful implementation of the Recovery Package 
and new approaches to follow-up provision are reliant on interoperability of healthcare 
records to enable effective communication and patient safety. 
 
There is an abundance of evidence that alternative approaches to follow-up are effective, 
command high levels of patient satisfaction and low risk of undiagnosed recurrence 
(Grunfeld et al, 1996; 1999; Moore et al, 2000; Brown 2002; Murchie et al, 2010; Beaver et 
al, 2009; 2012; 2017; Siddika et al, 2015). However, participants reported concern that 
commissioning of care and funding continues to be based on national tariffs for face to face 
hospital follow-up (Davies & Batehup, 2011; Frew et al, 2010; Jefford et al, 2013) in spite of 
the recommendations of the Living With and Beyond Cancer programme (DoH 2013).  The 
lack of standardised approaches to alternative follow-up was a concern from a legal 
perspective for some participants. There was a perceived risk of litigation should an 
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approach implemented in one Trust, but not in another, prove to be more effective for 
patients.  These concerns are not without foundation as the NHS has seen a dramatic rise in 
litigation with the cost of pay-outs rising from £28.6 billion in 2014-15 to£ 55.4 billion in 
2015-16 (CIPFA 2016).  There were differing levels of concern expressed between sites that 
had funding from cancer charities and those that did not. Those participants fortunate 
enough to work in sites receiving pump priming funding from cancer charities were 
concerned about the ability to continue with initiatives such as HNA’s and discharge 
summaries for all cancer patients once funding ceased. Whereas those who did not receive 
charitable funding were concerned about their ability to regularly complete a HNA with 
providing a HNA for all cancer patients seeming to be an impossible goal. This makes 
achieving the targets set out in the Achieving World-Class Cancer Outcomes strategy by 
2020 seem unattainable (DoH 2015). The HNA is pivotal to the successful implementation of 
the Recovery Package (DoH 2013;2015) but there was a diversity of view on whether the 
HNA was formally used in practice. The CNS role seemed to be the lynchpin for all aspects of 
the Recovery Package, although there was concern that they were an over stretched 
resource. The UK’s Cancer Patient Experience Survey (2014) reported that access to a CNS is 
the most important factor contributing to a positive patient experience and The 
Independent Cancer Taskforce (2015) supports participants views that not only are numbers 
of CNSs insufficient in many cancer specialities but their time is used inefficiently. Resources 
for referring patients for care that might be identified through a HNA were not available to 
all participants. This is concerning as Ahmed et al (2014) found that identifying patients’ 
needs but not addressing them had a negative impact on patients.  However, Health and 
Wellbeing clinics were viewed positively as a resource to supplement follow-up care and 
meet patients information needs although some participants felt that patients were 
frequently not referred at the right time for them.  
 
Initiatives to support the implementation of the Recovery Package were often reliant on the 
goodwill of NHS staff, which is not sustainable. The UK’s Achieving World-Class Cancer 
Outcomes Report (DoH, 2015) recommends that the Recovery Package and stratified care 
pathways be rolled out as quickly as possible. This is unlikely to happen outside of research 
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studies and pilot initiatives until commissioning of flexible approaches to follow-up care is 
secured (Davies & Batehup, 2011; Frew et al, 2010; Jefford et al, 2013).   
Limitations 
This was a small study, data collection was completed in 2015 and participants may give a 
different account of barriers and facilitators to implementing the Recovery Package if they 
were re-interviewed. However, Beaver et al (2019) reported that patients were not aware of 
key elements of the Recovery Package, namely the HNA, health and wellbeing clinics, cancer 
care reviews. Williamson et al, (2018) reported HNAs were not widely embedded into 
practice and specialist nurses were concerned that HNAs were becoming bureaucratic “tick-
box exercises” not conducted at times which met patients’ needs.  
 
Conclusion  
Only one site had implemented all aspects of the Recovery Package for patients with 
common cancers. Although charitable funding to pump prime initiatives had enabled 
progress to be made, the HNA was the only aspect of the recovery package that had been 
implemented for some patients in all sites.  
We recommend that effective utilisation of CNS’s and adequate training and support be 
provided for those staff expected to enable patients to self-manage and navigate further 
healthcare should they need it. Commissioning and appropriate funding of new approaches 
to follow-up that move the focus from secondary to primary care including rapid access 
back to secondary care is required. Effective communication between patients and primary 
and secondary would be facilitated by interoperability of health care records. Hence, 
engagement between commissioners and service providers is essential for a change in 
practice and long-term sustainability.  
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